Frank Lee, former CTO at Millennium Pharmaceuticals, to Lead Bioengineering Start-up EngeneOS | GenomeWeb

NEW YORK, March 2 - Former Millennium Pharmaceuticals chief technology officer Frank Lee has joined EngeneOS, a start-up biomolecular engineering company based in Cambridge, Mass.

Lee will become president and CEO of EngeneOS (pronounced ingenious), which counts Eric Lander as a member of its scientific advisory board. The company hopes to develop molecular machines using a combination of genomics, biotechnology, and the physical sciences, Lee said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.